project id: TCGA-SARC; case submitter id: TCGA-K1-A6RV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; age at index: 67; days to birth: -24701; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24701; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 158.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 141; initial weight: 240.0; sample id: 467e7743-8c7e-4a22-ace1-492a9bc17a89; sample submitter id: TCGA-K1-A6RV-01A; portion id: 78bfec2f-b7a7-4896-88e1-223426cc1f4c; portion submitter id: TCGA-K1-A6RV-01A-11; slide id: 53001c53-5bb7-445f-b9e4-71058ec88a4b; slide submitter id: TCGA-K1-A6RV-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 90.0; section location: TOP;